開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
ECB President LAGARDE: short-term inf expectations rising. Long-term inf expectations broadly stable around the target.
2026-06-11
ECB President LAGARDE: short-term inf expectations rising. Long-term inf expectations broadly stable around the target.
返回
其他消息
2026-06-11
CNN, citing three sources and the local fire department, reported a hazardous-materials incident inside the Pentagon that prompted lockdowns of multiple floors and corridors and evacuations. A Pentagon spokesman on Thursday confirmed building systems detected an air-quality issue and said precautionary measures were taken pending assessment of severity; affected areas were placed under shelter-in-place orders and emergency response teams were deployed to assist personnel.
CNN, citing three sources and the local fire department, reported a hazardous-materials incident inside the Pentagon that prompted lockdowns of multiple floors and corridors and evacuations. A Pentagon spokesman on Thursday confirmed building systems detected an air-quality issue and said precautionary measures were taken pending assessment of severity; affected areas were placed under shelter-in-place orders and emergency response teams were deployed to assist personnel.
2026-06-11
Under the 2026 adjustment plan, the application window closed on June 10 at 20:00. Regulators received 818 submissions: 570 for drugs not currently on the lists (509 applying only to the national basic list, 17 only to the commercial innovation list, 44 to both) and 248 for drugs already listed; total submissions rose vs 2025. The National Healthcare Security Administration (NHSA) will carry out formal review of each filing and publish preliminary results.
Under the 2026 adjustment plan, the application window closed on June 10 at 20:00. Regulators received 818 submissions: 570 for drugs not currently on the lists (509 applying only to the national basic list, 17 only to the commercial innovation list, 44 to both) and 248 for drugs already listed; total submissions rose vs 2025. The National Healthcare Security Administration (NHSA) will carry out formal review of each filing and publish preliminary results.
Chat with us
, powered by
LiveChat